ライフサイエンスコーパス: choroidal neovascularization

1 s, both normal and with macular degeneration/choroidal neovascularization.

2 arization in vivo in a laser injury model of choroidal neovascularization.

3 f an atrophic scar at the fovea or following choroidal neovascularization.

4 255 treatment-naive patients with subfoveal choroidal neovascularization.

5 nd a larger increase in total lesion area of choroidal neovascularization.

6 s investigated in the laser-induced model of choroidal neovascularization.

7 of the photoreceptor outer segments (OS) to choroidal neovascularization.

8 y contributor to increased susceptibility to choroidal neovascularization.

9 and thus reduce vascular leakage and retinal-choroidal neovascularization.

10 fluorescence and the volume of laser-induced choroidal neovascularization.

11 each eye of WT and COX-2 null mice to induce choroidal neovascularization.

12 of reactive oxygen species, contributing to choroidal neovascularization.

13 ent in vitro and in a model of laser-induced choroidal neovascularization.

14 ischemic retinopathy (OIR) and laser-induced choroidal neovascularization.

15 acterized by drusen, geographic atrophy, and choroidal neovascularization.

16 VEGF-A secretion and angiogenic phenotype in choroidal neovascularization.

17 insight into the pathogenesis of corneal and choroidal neovascularization.

18 oxygen-induced retinopathy and laser-induced choroidal neovascularization.

19 the efficacy and safety of PDT for treating choroidal neovascularization.

20 d macular degeneration and other diseases of choroidal neovascularization.

21 r deposits, Bruch's membrane thickening, and choroidal neovascularization.

22 d in the most effective means of identifying choroidal neovascularization.

23 tion and the risks of retinal detachment and choroidal neovascularization.

24 MVECs suggest it may play a critical role in choroidal neovascularization.

25 F-induced subretinal neovascularization, and choroidal neovascularization.

26 degeneration is to avoid the development of choroidal neovascularization.

27 d strong up-regulation of alpha(5)beta(1) in choroidal neovascularization.

28 erlying vasculature, geographic atrophy, and choroidal neovascularization.

29 ssion of Ang2 also resulted in regression of choroidal neovascularization.

30 ies exploring new therapeutic approaches for choroidal neovascularization.

31 tion of nitric oxide (NO) in macrophages and choroidal neovascularization.

32 2 as a novel therapeutic target for reducing choroidal neovascularization.

33 nd photoreceptors and can be associated with choroidal neovascularization.

34 fundus changes and potentially of subsequent choroidal neovascularization.

35 cterized by fibrous membrane formation after choroidal neovascularization.

36 D OCT in 44% of the cases with no associated choroidal neovascularization.

37 ive cystoid macular edema or exacerbation of choroidal neovascularization.

38 e a strong risk factor in the development of choroidal neovascularization.

39 n strongly implicated in the pathogenesis of choroidal neovascularization.

40 sumed Ocular Histoplasmosis Syndrome-related choroidal neovascularization.

41 fundus changes and potentially of subsequent choroidal neovascularization.

42 larger increase in mean total lesion area of choroidal neovascularization (3.00 mm(2)) than eyes with

43 xtreme cases, apoE4 mice also develop marked choroidal neovascularization, a hallmark of exudative AM

44 Current treatments for choroidal neovascularization, a major cause of blindness

45 inal pigment epithelium (RPE) abnormalities, choroidal neovascularization, acquired vitelliform lesio

46 eposition of drusen-like material or aborted choroidal neovascularization adjacent to the natural bre

47 g of the macular choroid (affected or not by choroidal neovascularization), along with the significan

48 Likewise, mouse laser-induced choroidal neovascularization, an injury that involves LP

49 l fibrosis after regression of laser-induced choroidal neovascularization and a decrease in mesenchym

50 These retinal lesions can be associated with choroidal neovascularization and central serous choriore

51 suppress hemangiogenesis in mouse models of choroidal neovascularization and dermal wound healing in

52 eripapillary atrophy were also common, while choroidal neovascularization and Fuchs spot were rare.

53 ration (AMD) often involve persons with both choroidal neovascularization and geographic atrophy (GA)

54 Some patients also develop choroidal neovascularization and glaucoma.

55 ivo screening strategy with rodent models of choroidal neovascularization and iterative compound desi

56 oidal choroidal vasculopathy is a variant of choroidal neovascularization and neovascular age related

57 We document choroidal neovascularization and other AMD-like ocular p

58 a role in the development and maintenance of choroidal neovascularization and provides a target for t

59 F/rGel also caused significant regression of choroidal neovascularization and regression of retinal n

60 dels of neovascular pathology [laser-induced choroidal neovascularization and the very low density li

61 s of ocular neovascularization: laser injury choroidal neovascularization and VEGF-induced corneal ne

62 y criteria for CATT specified that eyes have choroidal neovascularization and visual acuity between 2

63 phenotypes for the disease: neovascular AMD (choroidal neovascularization) and geographic atrophy.

64 ot, myopic chorioretinal atrophy, and myopic choroidal neovascularization) and optic disc (optic nerv

65 They may represent an early sign of active choroidal neovascularization, and should prompt to early

66 hy developed in areas previously occupied by choroidal neovascularization, and the other 5 eyes had a

67 Four stage 3 eyes had associated choroidal neovascularization, and these eyes had 20/60 p

68 lial growth factor antagonists also suppress choroidal neovascularization, and transgenic expression

69 ng oxygen-induced retinopathy, laser-induced choroidal neovascularization, and transgenic mouse model

70 ere older age, VA of 20/40 or better, larger choroidal neovascularization area, presence of geographi

71 6.0 diopters with the presence of subretinal/choroidal neovascularization as indicated by Internation

72 models with deficient or spontaneous retinal/choroidal neovascularization, as well as models with ind

73 in ischemic retina and significantly reduced choroidal neovascularization at Bruch's membrane rupture

74 se vision than their mother, despite lacking choroidal neovascularization, because of the extent of p

75 ith UPR inhibitors or siRNAs reduced retinal/choroidal neovascularization by a further 25% to 40%, an

76 s may contribute to macular degeneration and choroidal neovascularization by causing ER stress leadin

77 Digoxin suppresses retinal and choroidal neovascularization by reducing HIF-1alpha leve

78 ells (HSCs) have been shown to contribute to choroidal neovascularization by signaling through the SD

79 In age-related macular degeneration, choroidal neovascularization can be observed without the

80 rly onset macular degenerative disease, with choroidal neovascularization causing a loss of vision in

81 risk of scarring were predominantly classic choroidal neovascularization (CNV) (aHR, 3.1; CI, 2.4-3.

82 ociations between all rare pLoF variants and choroidal neovascularization (CNV) (OR, 1.34; 95% CI, 1.

83 the mechanism of cell death in laser-induced choroidal neovascularization (CNV) after photodynamic th

84 peptide fragments on vessel sprouting and on choroidal neovascularization (CNV) after subconjunctival

85 if they had low vision in the fellow eye and choroidal neovascularization (CNV) along with (1) no res

86 lemonitoring for early detection of incident choroidal neovascularization (CNV) among patients with a

87 Choroidal neovascularization (CNV) and capillary dilatio

88 Inflammation and immune cells regulate choroidal neovascularization (CNV) and could become ther

89 gamma-secretase could inhibit laser-induced choroidal neovascularization (CNV) and if this was assoc

90 in two in vivo murine models, laser-induced choroidal neovascularization (CNV) and melanoma growth.

91 Wet AMD includes typical choroidal neovascularization (CNV) and polypoidal choroi

92 Eyes with advanced choroidal neovascularization (CNV) and poor visibility o

93 s investigated the effects of doxycycline on choroidal neovascularization (CNV) and regulation of MMP

94 cting and quantifying experimentally induced choroidal neovascularization (CNV) and vascular changes

95 .96 to 0.97 for quantitative measurements of choroidal neovascularization (CNV) area and total area o

96 Total choroidal neovascularization (CNV) area increased by 1.1

97 cholesterolemia, worse visual acuity, larger choroidal neovascularization (CNV) area, retinal angioma

98 on methods that are used to detect new-onset choroidal neovascularization (CNV) as a result of age-re

99 s to develop and characterize a rat model of choroidal neovascularization (CNV) as occurs in age-rela

100 es of previously untreated, active subfoveal choroidal neovascularization (CNV) associated with AMD w

101 l (ie, ocular) complement factor H (CFH) and choroidal neovascularization (CNV) associated with wet a

102 The relative risk for choroidal neovascularization (CNV) based on drusen area,

103 In the eye, choroidal neovascularization (CNV) causes blindness in p

104 wever, these mice develop significantly less choroidal neovascularization (CNV) compared to wild-type

105 ace changes over time and their influence on choroidal neovascularization (CNV) development.

106 of fluorescein angiograms from patients with choroidal neovascularization (CNV) due to age-related ma

107 also called FLT1), in patients with blinding choroidal neovascularization (CNV) from age-related macu

108 to identify patients with exudative AMD and choroidal neovascularization (CNV) in 1 or both eyes res

109 suppress retinal vessel leakage and inhibit choroidal neovascularization (CNV) in a laser-induced CN

110 Choroidal neovascularization (CNV) in age-related macula

111 ibitor of pathological angiogenesis, such as choroidal neovascularization (CNV) in age-related macula

112 raphy angiography (OCTA) in the detection of choroidal neovascularization (CNV) in age-related macula

113 study, we describe a new method for inducing choroidal neovascularization (CNV) in C57BL/6 mice, an a

114 acteristics and natural history of quiescent choroidal neovascularization (CNV) in geographic atrophy

115 macular edema (DME), retinal vein occlusion, choroidal neovascularization (CNV) in high myopia, and o

116 ) has been implicated in the pathogenesis of choroidal neovascularization (CNV) in neovascular AMD, w

117 e (CAM) assay and laser-induced experimental choroidal neovascularization (CNV) in rats.

118 nhibitor, 10 weeks post-injection suppresses choroidal neovascularization (CNV) in rats.

119 ry outcome measure was time to occurrence of choroidal neovascularization (CNV) in the study eye.

120 cell adhesion and proliferation in vitro and choroidal neovascularization (CNV) in vivo was examined.

121 Adjacent to active choroidal neovascularization (CNV) in wet AMD, CC dropou

122 Here we report that choroidal neovascularization (CNV) incited by injury was

123 Choroidal neovascularization (CNV) is a defining feature

124 Choroidal neovascularization (CNV) is a major cause of v

125 Choroidal neovascularization (CNV) is a severe complicat

126 Laser-induced choroidal neovascularization (CNV) is a widely used mode

127 Choroidal neovascularization (CNV) is the end point of s

128 Choroidal neovascularization (CNV) is the leading cause

129 luded lower BCVA, younger age, smaller total choroidal neovascularization (CNV) leakage area, smaller

130 acterize techniques for measuring changes in choroidal neovascularization (CNV) lesion size and fluor

131 change in angiographic total lesion size and choroidal neovascularization (CNV) lesion size.

132 Eyes with subfoveal choroidal neovascularization (CNV) lesions had a lower g

133 onstrated by increased size of laser-induced choroidal neovascularization (CNV) lesions.

134 AMG 386 was tested in a laser-induced choroidal neovascularization (CNV) model in monkeys usin

135 In the laser-induced choroidal neovascularization (CNV) model, the CNV area w

136 treatment/intervention modality of the laser choroidal neovascularization (CNV) model, the efficacy o

137 tion of laser rupture of Bruch's membrane, a choroidal neovascularization (CNV) model.

138 -induced retinopathy (OIR) and laser-induced choroidal neovascularization (CNV) models.

139 he corneal micropocket and the laser-induced choroidal neovascularization (CNV) mouse models.

140 Choroidal neovascularization (CNV) of the macular area o

141 were subdivided into 3 groups: eyes without choroidal neovascularization (CNV) or chorioretinal atro

142 s with AMD with severe atrophy due to either choroidal neovascularization (CNV) or geographic atrophy

143 degeneration (AMD) to the advanced stages of choroidal neovascularization (CNV) or geographic atrophy

144 lantation of 7KCh-exposed microglia promoted choroidal neovascularization (CNV) relative to control m

145 elial progenitor cells (EPCs) are present in choroidal neovascularization (CNV) secondary to age-rela

146 ty required angiographic and OCT evidence of choroidal neovascularization (CNV) secondary to age-rela

147 Patients with subfoveal choroidal neovascularization (CNV) secondary to AMD were

148 ty of Ranibizumab in Patients with Subfoveal Choroidal Neovascularization (CNV) Secondary to AMD, Pro

149 A total of 151 patients with subfoveal choroidal neovascularization (CNV) secondary to neovascu

150 DRS letters, angiographic total lesion size, choroidal neovascularization (CNV) size, and optical coh

151 was an 85.5% mean reduction from baseline in choroidal neovascularization (CNV) size.

152 In contrast to the choroidal neovascularization (CNV) subtype, the genetic

153 ecrosis factor (TNF)-alpha has been found in choroidal neovascularization (CNV) surgically removed fr

154 was more prominent in patients with classic choroidal neovascularization (CNV) than those with occul

155 -induced retinopathy (OIR) and laser-induced choroidal neovascularization (CNV) to assess the contrib

156 Choroidal neovascularization (CNV) was manually segmente

157 corneal neovascularization and laser-induced choroidal neovascularization (CNV) were examined in TIMP

158 tinopathy (OIR) model and the laser model of choroidal neovascularization (CNV) were used to test the

159 t epithelium derived factor (PEDF) may cause choroidal neovascularization (CNV), a key event in wet A

160 To investigate the genetic contribution to choroidal neovascularization (CNV), a leading cause of b

161 The molecular pathogenesis of choroidal neovascularization (CNV), an angiogenic proces

162 play an important role in the development of choroidal neovascularization (CNV), an integral componen

163 Older age, larger area of choroidal neovascularization (CNV), and elevation of ret

164 data from retinas treated with laser-induced choroidal neovascularization (CNV), bright white-light e

165 In 2 eyes with secondary choroidal neovascularization (CNV), distinct en face SS-

166 normal growth of choroidal blood vessels, or choroidal neovascularization (CNV), is a hallmark of the

167 t epithelium derived factor (PEDF) may cause choroidal neovascularization (CNV), key event of wet AMD

168 -induced retinopathy (OIR) and laser-induced choroidal neovascularization (CNV), mimicking hypoxia-me

169 Choroidal neovascularization (CNV), the advanced stage o

170 arly always precede and increase the risk of choroidal neovascularization (CNV), the late vision-thre

171 ibodies within retinal lesions in a model of choroidal neovascularization (CNV).

172 s ligand (FasL) function in a mouse model of choroidal neovascularization (CNV).

173 ing hyperreflective material consistent with choroidal neovascularization (CNV).

174 ch's membrane (BrM) into the retina, forming choroidal neovascularization (CNV).

175 te AMD subtypes; geographic atrophy (GA) and choroidal neovascularization (CNV).

176 that occur in vivo during the development of choroidal neovascularization (CNV).

177 he wet form of the disease, characterized by choroidal neovascularization (CNV).

178 AMD-related vision loss, is characterized by choroidal neovascularization (CNV).

179 plex using the murine model of laser-induced choroidal neovascularization (CNV).

180 ive B6-gld mice were laser treated to induce choroidal neovascularization (CNV).

181 cular degeneration (AMD) is characterized by choroidal neovascularization (CNV).

182 imens from mice treated with laser to induce choroidal neovascularization (CNV).

183 tance of PLCgamma1 and c-Cbl in experimental choroidal neovascularization (CNV).

184 to sites of complement activation, in mouse choroidal neovascularization (CNV).

185 MD, including an increased susceptibility to choroidal neovascularization (CNV).

186 ay have a permissive effect on the growth of choroidal neovascularization (CNV).

187 e retina, an abnormality also referred to as choroidal neovascularization (CNV).

188 ted the role of nAChR in the pathogenesis of choroidal neovascularization (CNV).

189 ay plays a central role in the laser-induced choroidal neovascularization (CNV).

190 ic therapy (PDT) in a laser-induced model of choroidal neovascularization (CNV).

191 ys of complement activation in laser-induced choroidal neovascularization (CNV).

192 5 fellow eyes of 55 patients with unilateral choroidal neovascularization (CNV).

193 CGC-11144 and CGC-11150 in a mouse model of choroidal neovascularization (CNV).

194 moses also occur in various animal models of choroidal neovascularization (CNV).

195 ous proliferation (RAP) lesions, and classic choroidal neovascularization (CNV).

196 ent white dot syndrome (MEWDS) who developed choroidal neovascularization (CNV).

197 of irreversible blindness and manifests with choroidal neovascularization (CNV).

198 cular degeneration (AMD) is characterized by choroidal neovascularization (CNV).

199 permeability, while there was no evidence of choroidal neovascularization (CNV).

200 were also more susceptible to laser-induced choroidal neovascularization (CNV).

201 drusen; retinal pigment epithelial changes; choroidal neovascularization (CNV); atrophy; and hypoaut

202 nfidence interval [CI], 53-442), followed by choroidal neovascularization (CNV; OR, 90; 95% CI, 26-31

203 features from pathologic RPE detachments and choroidal neovascularizations (CNVs).

204 had reduced dihydroethidium fluorescence and choroidal neovascularization compared with wild-type con

205 Bilateral choroidal neovascularization developed in only 1 patient

206 The treatment options of choroidal neovascularization due to age-related macular

207 ed from 1134 of 1146 patients with subfoveal choroidal neovascularization due to AMD with minimally c

208 Cs suggests a possible role for potentiating choroidal neovascularization during the pathology of neo

209 cious in mouse models of geographic atrophy, choroidal neovascularization, graft-versus-host disease,

210 ous in vivo systems, including laser-induced choroidal neovascularization, growth factor-induced corn

211 Stage 3 eyes without choroidal neovascularization had a mean presenting visua

212 betic macular edema, retinal vein occlusion, choroidal neovascularization) have shown promising resul

213 Areas of geographic atrophy and choroidal neovascularization imaged by FA were depicted

214 al neovascularization in 3 eyes and inactive choroidal neovascularization in 1 eye.

215 silar insufficiency in 2.8% of eyes; non-AMD choroidal neovascularization in 2.3% of eyes; retinitis

216 f a hyperflow signal corresponding to active choroidal neovascularization in 3 eyes and inactive chor

217 pressed initiation and growth of spontaneous choroidal neovascularization in a mouse model, and the c

218 al scars, which are thought to progress into choroidal neovascularization in a small proportion of pa

219 , and is likely to play an important role in choroidal neovascularization in age-related macular dege

220 fied as a risk factor for the development of choroidal neovascularization in age-related macular dege

221 y for the Treatment of Predominantly Classic Choroidal Neovascularization in AMD (ANCHOR) trials show

222 s, retinal vascular leakage, and retinal and choroidal neovascularization in animal models of ROP and

223 EGF signaling exists and may be important in choroidal neovascularization in human age-related macula

224 s immunofluorescent staining for rGel within choroidal neovascularization in mice and regression of t

225 travitreal administration of oligo G reduces choroidal neovascularization in mice.

226 ote various pathologic conditions, including choroidal neovascularization in models of neovascular ag

227 s showed excellent short-term suppression of choroidal neovascularization in patients with exudative

228 aditional multimodal imaging, helps diagnose choroidal neovascularization in patients with Malattia L

229 rsy that surrounds the optimal treatment for choroidal neovascularization in patients with presumed o

230 ies demonstrated that aflibercept suppresses choroidal neovascularization in several animal models.

231 We used a laser-injury wound model of choroidal neovascularization in the eye to determine the

232 yes and retinal hemorrhages with an apparent choroidal neovascularization in the left eye, which was

233 n, the authors used a model of laser-induced choroidal neovascularization in the mouse eye and invest

234 reduce pro-angiogenic isoforms, and prevent choroidal neovascularization in vivo.

235 efined as HM with the presence of subretinal/choroidal neovascularization indicated by the ICD-9-CM d

236 Subsequent choroidal neovascularization is limited to the area dema

237 ted macular degeneration eyes with subfoveal choroidal neovascularization is uniform across a wide ra

238 inistration of IL-4 attenuates laser-induced choroidal neovascularization (L-CNV) due to specific IL-

239 -induced retinopathy (OIR) and laser-induced choroidal neovascularization (LCNV).

240 The pattern of choroidal neovascularization lesion size enlargement in

241 The main determinant of choroidal neovascularization lesion size enlargement is

242 Pigmented mice with laser-induced choroidal neovascularization lesions (n = 7 eyes) were a

243 e first realistic means to address subfoveal choroidal neovascularization lesions from age-related ma

244 ed BRB leakage and the size of laser-induced choroidal neovascularization lesions.

245 ffect on both area and number of spontaneous choroidal neovascularization lesions.

246 ctional role for TLR2 in the pathogenesis of choroidal neovascularization, likely by promoting inflam

247 Choroidal neovascularization location as well as retinal

248 outcomes in eyes with treatment-naive myopic choroidal neovascularization (mCNV) in the United States

249 Furthermore, analysis in a laser-induced choroidal neovascularization model showed that depletion

250 nd showed good efficacy in the laser induced choroidal neovascularization model.

251 ssel growth were also determined in a murine choroidal neovascularization model.

252 pathological angiogenesis in a laser-induced choroidal neovascularization mouse model.

253 or ATF6 in the oxygen-induced retinopathy or choroidal neovascularization mouse models caused an appr

254 inal hemorrhage (n = 3, 0.9%), active myopic choroidal neovascularization (n = 3, 0.9%), and no case

255 Retinal and choroidal neovascularization (NV) and vascular leakage c

256 In contrast, choroidal neovascularization occurred equally well in bi

257 Furthermore, choroidal neovascularization occurred in 15% of the mice

258 Stage 3 resembles occult choroidal neovascularization, occurs primarily in older

259 d associations of ARMS2 and CFH with type of choroidal neovascularization on fluorescein angiography

260 ioretinopathy, and did not have a history of choroidal neovascularization or photodynamic therapy.

261 -related macular degeneration independent of choroidal neovascularization or retinal pigment epitheli

262 95% CI, 1.35-6.08; P = .006), larger area of choroidal neovascularization (OR for a >4-disc area vs <

263 ors with early-stage AMD (P = 0.028), active choroidal neovascularization (P = 0.020), and disciform

264 l loss may occur during a preoccult phase of choroidal neovascularization, prior to the development o

265 inal vasculitis, multifocal choroiditis, and choroidal neovascularization, providing for the first ti

266 r of patients with treatment-naive subfoveal choroidal neovascularization receiving intravitreal rani

267 n 2 (12%), a dome-shaped macula in 1 (6%), a choroidal neovascularization-related subretinal scar in

268 retinal angiomatous proliferation, and mixed choroidal neovascularization, respectively.

269 ow, the most common form of late-stage AMD - choroidal neovascularization - responds to treatment wit

270 lar Endothelial Growth Factor in Age-Related Choroidal Neovascularization) results were not released

271 classic or occult (with no classic lesions) choroidal neovascularization secondary to age-related ma

272 en-label study in 15 patients with subfoveal choroidal neovascularization secondary to AMD at a clini

273 l Neovascularization with or without Classic Choroidal Neovascularization Secondary to AMD Study), wh

274 participants, aged >/=50 years, with active choroidal neovascularization secondary to AMD.

275 For choroidal neovascularization secondary to inflammatory d

276 escein-negative intraretinal cystic changes, choroidal neovascularization, serous retinal elevations

277 photoreceptor degeneration, and exaggerated choroidal neovascularization similar to AMD.

278 mL vs 69.3 pg/mL) and did not correlate with choroidal neovascularization size and lesion type.

279 In the B50 group, choroidal neovascularization size was smaller (0.73 vs 1

280 ular Degeneration: Detection of Onset of new Choroidal neovascularization Study (AMD DOC Study) evalu

281 f visual acuity, on average, at detection of choroidal neovascularization than do individuals using s

282 pegaptanib sodium and PDT on lesion size in choroidal neovascularization than with each monotherapy.

283 The mother had choroidal neovascularization that was treated with bevac

284 giogenic isoforms of VEGF-A as inhibitors of choroidal neovascularization, the authors used a model o

285 ntagonist, caused significant suppression of choroidal neovascularization; the area of neovasculariza

286 classic or occult (with no classic lesions) choroidal neovascularization to receive 24 monthly intra

287 ependence on VEGF-A in models of corneal and choroidal neovascularization using a combination of reag

288 Choroidal neovascularization was diagnosed in 8 of 27 ey

289 tioned CD200R(-/-) BMMPhi, and laser-induced choroidal neovascularization was enhanced in CD200R-defi

290 Choroidal neovascularization was generated by laser inju

291 Choroidal neovascularization was generated in mice using

292 Choroidal neovascularization was induced by 532-nm diode

293 ralizing protein can result in regression of choroidal neovascularization, which is sometimes associa

294 itreal morpholino injection suppressed laser choroidal neovascularization while increasing sKDR.

295 or the average person with classic subfoveal choroidal neovascularization, while laser photocoagulati

296 Parstatin potently inhibited choroidal neovascularization with an IC(50) of approxima

297 detachment associated with occult subfoveal choroidal neovascularization with intravitreal ranibizum

298 ty of Ranibizumab in Subjects with Subfoveal Choroidal Neovascularization with or without Classic Cho

299 or the treatment of occult/minimally classic choroidal neovascularization with ranibizumab is greater

300 8(-/-)Abca4(-/-) mice for 4 months prevented choroidal neovascularization without changing retinal VE